A bill to establish an emerging pathogen preparedness program within the Food and Drug Administration to improve regulatory oversight of medical countermeasures for future pandemics.
Emerging Pathogen Preparedness Program Authorization Act
This bill establishes a program in the Food and Drug Administration's Center for Biologics Evaluation and Research to support the development and approval of biological countermeasures. Authorized activities include the development of quality measures for countermeasures, surveillance programs to monitor countermeasures, and research and development of platform vaccine technology to support emergency use authorization requests.
Placed on Senate Legislative Calendar under General Orders. Calendar No. 202.
Introduced in Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line